Single-cell sequencing in systemic lupus erythematosus
Authors:
- 3 June 2026
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 35 (11) , 1103-1119
Abstract
Background: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by heterogeneous clinical manifestations and multi-organ involvement. Current understanding of SLE pathogenesis remains limited, particularly due to the cellular and molecular diversity of immune cells across tissues. Therefore, a comprehensive review synthesizing recent advances in applying single-cell technologies to SLE research is urgently needed to bridge this knowledge gap. Technology: Single-cell RNA sequencing (scRNA-seq) provides high-resolution transcriptomic profiling at the single-cell level. This technology facilitates the identification of rare cell subsets, the characterization of cellular states, and the elucidation of disease-specific gene expression patterns. This technology has been applied to various SLE sample types, including peripheral blood, kidney, skin, and bone marrow. Results: ScRNA-seq has revealed distinct immune cell subpopulations and their functional alterations in SLE, including aberrant B- and T-cell subsets, dysregulated interferon-stimulated genes, and pathogenic low-density granulocytes. Crucially, by deconvoluting this cellular heterogeneity, these high-resolution insights bridge the gap between fundamental pathogenesis and clinical application, uncovering cell-specific pathways that can be harnessed as actionable therapeutic targets and prognostic biomarkers. Integration with spatial transcriptomics and machine learning further enhances research capabilities. These tools allow for mapping disease-specific immune niches and predicting clinical outcomes. Ultimately, these findings underscore the transformative potential of scRNA-seq in decoding SLE pathogenesis and guiding future targeted therapies.Keywords
This publication has 111 references indexed in Scilit:
- Systemic Lupus ErythematosusJAMA, 2024
- Single‐Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus ErythematosusArthritis & Rheumatology, 2024
- CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus ErythematosusArthritis & Rheumatology, 2024
- Immune landscape and the key role of APOE+ monocytes of lupus nephritis under the single‐cell and spatial transcriptional vistaClinical and Translational Medicine, 2023
- Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐AnalysisArthritis & Rheumatology, 2016
- Structure and Function of Renal Macrophages and Dendritic Cells From Lupus‐Prone MiceArthritis & Rheumatology, 2014
- Immune aging and autoimmunityCellular and Molecular Life Sciences, 2012
- Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Arthritis & Rheumatism, 2011
- Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosusArthritis & Rheumatism, 2004
- Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cellsImmunity, 1995